Healthcare


 Opthea Restructures Strategy Following Clinical Trial Setbacks

Opthea Restructures Strategy Following Clinical Trial Setbacks

April 10, 2025 11:30 AM AEST| By Team Kalkine Media

Highlights,Opthea discontinues late-stage clinical studies after failing to meet drug efficacy benchmarks,Significant workforce downsizing initiated to realign operations and preserve resources,Company engages in discussions with backers while tradin...

 Melanie Farris Joins (ASX:PTX) Prescient Therapeutics Board to Enhance Governance and Strategy

Melanie Farris Joins (ASX:PTX) Prescient Therapeutics Board to Enhance Governance and Strategy

April 10, 2025 11:24 AM AEST| By Team Kalkine Media

Highlights,Melanie Farris,appointed,as non-executive director at Prescient Therapeutics.,Farris to spearhead audit and risk committee, bolstering board oversight.,(PTX) Prescient continues to advance its precision oncology trials.,Prescient Therapeut...

 Expanding Horizons: Osteopore (ASX:OSX) Gains European Approval for Custom Implants

Expanding Horizons: Osteopore (ASX:OSX) Gains European Approval for Custom Implants

April 09, 2025 03:51 PM AEST| By Team Kalkine Media

Highlights,Osteopore (OSX) receives European approval for specialized implants.,Projected growth driven by demand in cranial and orthopaedic markets.,Exclusive distribution partnership established with Zimmer Biomet.,Osteopore (ASX:OSX), a pioneer in...

 Expanding Horizons: Osteopore Gains Vital EU Approval for Custom Implants

Expanding Horizons: Osteopore Gains Vital EU Approval for Custom Implants

April 09, 2025 03:39 PM AEST| By Team Kalkine Media

Highlights,Osteopore (OSX) receives critical EU MDR approval for its tailored implants.,The approval paves the way for growth in the European custom implant markets.,Strategic partnership opportunities, including with Zimmer Biomet, are set to expand...

 Unveiling Sonic Healthcare's Financial Landscape in 2025: A Comprehensive Overview

Unveiling Sonic Healthcare's Financial Landscape in 2025: A Comprehensive Overview

April 09, 2025 02:23 PM AEST| By Team Kalkine Media

Highlights,SHL's revenue shows steady growth with a modest CAGR of 0.8% over the last three years.,Sonic Healthcare (SHL) experiences a significant shift in profitability and debt management.,Current valuation suggests SHL shares may be trading below...

 Biotech stocks that withstood the challenges of April 2 are now facing the pressure of Trump's latest pharmaceutical threat.

Biotech stocks that withstood the challenges of April 2 are now facing the pressure of Trump's latest pharmaceutical threat.

April 09, 2025 01:30 PM AEST| By Team Kalkine Media

Highlights:,CSL Ltd (ASX:CSL), Mesoblast (ASX:MSB), and Cochlear Ltd (ASX:COH) have seen shifts in share performance following tariff-related developments.,The healthcare sector emerged as the worst performer on the ASX 200 after renewed uncertainty...

 Market Impact: New U.S. Tariffs to Affect Pharmaceutical Sector

Market Impact: New U.S. Tariffs to Affect Pharmaceutical Sector

April 09, 2025 12:56 PM AEST| By Team Kalkine Media

Highlights,President Trump announces new tariffs on pharmaceuticals.,(CSL) shares fall following tariff news.,U.S. trade policies could reshape global pharmaceutical trade dynamics.,In a recent development that could significantly impact the pharmace...

 Orthocell Gains Ground: Brazilian Market Entry to Boost Global Presence

Orthocell Gains Ground: Brazilian Market Entry to Boost Global Presence

April 09, 2025 12:55 PM AEST| By Team Kalkine Media

Highlights,Orthocell,(OCC) approved for Striate+ in Brazil.,Strategic entry into a $65 million market.,Planned expansion across Latin America.,Orthocell (ASX:OCC), an innovator in regenerative medicine, has successfully obtained regulatory approval f...

 Transurban Group's (ASX:TCL) Steady Climb: A Look at Its Current Position and Future Prospects

Transurban Group's (ASX:TCL) Steady Climb: A Look at Its Current Position and Future Prospects

April 09, 2025 12:48 PM AEST| By Team Kalkine Media

Highlights,(TCL) has,witnessed,a 1.0% rise since the beginning of 2025.,Offers a compelling dividend yield of 4.57%, higher than its 5-year average.,Positioned to,benefit,from consistent government infrastructure spending and population growth.,Trans...

 Insider Confidence in Amplia Therapeutics Despite Market Fluctuations

Insider Confidence in Amplia Therapeutics Despite Market Fluctuations

April 09, 2025 11:47 AM AEST| By Team Kalkine Media

Highlights,Significant insider purchases reflect confidence in (ATX).,Recent,market value decline challenges,initial,optimism.,Insider ownership suggests long-term commitment to company growth.,Over the past year, insiders of Amplia Therapeutics Limi...

 Pro Medicus (ASX:PME) Gains Momentum Amid Market Volatility: Analyst Upgrade Highlights

Pro Medicus (ASX:PME) Gains Momentum Amid Market Volatility: Analyst Upgrade Highlights

April 08, 2025 03:16 PM AEST| By Team Kalkine Media

Highlights,Pro Medicus receives upgrade to overweight status.,Shares bounce back with a 6% increase.,Unchanged price target reflects ongoing confidence.,In a recent market update, Pro Medicus (ASX:PME), a leading health imaging software provider, has...

 Impressive Growth in Occupancy Sales Drives Summerset Group's Q1 Momentum

Impressive Growth in Occupancy Sales Drives Summerset Group's Q1 Momentum

April 08, 2025 02:28 PM AEST| By Team Kalkine Media

Highlights,Robust Sales Growth,: Summerset achieves a 14% year-over-year increase in Q1 2025.,Geographic Expansion,: Sales flourish across diverse New Zealand regions.,Future Developments,: Expansion plans include new homes and a village center in Au...

 Cochlear poised to avoid tariffs as countries begin negotiations with Trump

Cochlear poised to avoid tariffs as countries begin negotiations with Trump

April 08, 2025 11:30 AM AEST| By Team Kalkine Media

Highlights:,Cochlear Limited aligns with international trade classifications to maintain duty-free access for hearing implants.,Recent tariff developments underscore the importance of regulatory frameworks in the global medical device landscape.,Key...

 Why the Drop in Aroa Biosurgery Limited's (ASX:ARX) Share Price Shouldn't Surprise Investors

Why the Drop in Aroa Biosurgery Limited's (ASX:ARX) Share Price Shouldn't Surprise Investors

April 08, 2025 10:31 AM AEST| By Team Kalkine Media

Highlights,Aroa Biosurgery (ARX) shares drop 26% in 30 days.,P/S ratio stands at 1.8x, under industry average.,Future growth projections fall below industry trends.,Aroa Biosurgery Limited, trading under the ticker,(,ASX:ARX),, has witnessed a signif...

 ASX Healthcare Stock Trading Well Below Pandemic Highs with Consistent Dividends

ASX Healthcare Stock Trading Well Below Pandemic Highs with Consistent Dividends

April 07, 2025 04:35 PM AEST| By Team Kalkine Media

Highlights,Healthcare group Sonic Healthcare has seen a significant decline from its peak during the pandemic,The company operates internationally, offering pathology and diagnostic services,It has delivered consistent dividend growth across many yea...

 Mach7 Technologies Faces Market Pressure Amid Sluggish Growth Outlook

Mach7 Technologies Faces Market Pressure Amid Sluggish Growth Outlook

April 07, 2025 04:33 PM AEST| By Team Kalkine Media

Highlights,Mach7 Technologies has experienced a notable share price drop in recent weeks,The company’s price-to-sales ratio trails the broader healthcare services sector,Revenue growth expectations remain below industry projections,Mach7 Technologies...

 Atomo Diagnostics (ASX:AT1) Broadens Reach with Major Initiatives in Australia and New Zealand

Atomo Diagnostics (ASX:AT1) Broadens Reach with Major Initiatives in Australia and New Zealand

April 07, 2025 01:31 PM AEST| By Team Kalkine Media

Highlights,Expansion in Australia,:,Atomo,Diagnostics rolls out free HIV self-tests across Australia.,Launch in New Zealand,: Introduction of HIV self-test kits through Chemist Warehouse.,Executive Insight,: CEO emphasizes the importance of accessibi...

 Exploring Regis Healthcare's (ASX:REG) Revenue Growth and Market Position

Exploring Regis Healthcare's (ASX:REG) Revenue Growth and Market Position

April 07, 2025 01:29 PM AEST| By Team Kalkine Media

Highlights,Exceptional Revenue Growth,: Regis Healthcare (REG) has shown impressive revenue growth trends over recent years.,Comparative P/S Ratio,: Its price-to-sales ratio aligns closely with the industry average, despite higher growth forecasts.,h...

 Exploring Alcidion Group's Path to Profitability: A Closer Look at Its Strategic Progress

Exploring Alcidion Group's Path to Profitability: A Closer Look at Its Strategic Progress

April 07, 2025 11:20 AM AEST| By Team Kalkine Media

Highlights,Alcidion,Group (ALC) nears its breakeven point.,Projected to turn a profit by 2026 based on current growth forecasts.,Unique,position with no debt enhances financial stability.,Alcidion Group (ASX:ALC), a key player in healthcare technolog...

 Research reveals that Nyrada's leading medication can avert secondary brain injury.

Research reveals that Nyrada's leading medication can avert secondary brain injury.

April 07, 2025 10:30 AM AEST| By Team Kalkine Media

Highlights:,Nyrada Inc has released new findings from a study showing its drug candidate NYR-BI03 demonstrates neuroprotective effects following traumatic brain injury.,The research, conducted with the University of Sydney, Walter Reed Army Institute...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.